Implementation of the Prostate Cancer Prevention Trial (PCPT)
- 30 April 2004
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 25 (2) , 203-222
- https://doi.org/10.1016/j.cct.2003.11.007
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Minority Recruitment in the Prostate Cancer Prevention TrialAnnals of Epidemiology, 2000
- Design of the Prostate Cancer Prevention Trial (PCPT)Controlled Clinical Trials, 1995
- ChemopreventionCA: A Cancer Journal for Clinicians, 1995
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- Chemoprevention strategies for prostate cancer: The role of 5α-reductase inhibitorsJournal of Cellular Biochemistry, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosteroneJournal of Pharmacy and Pharmacology, 1984